Following the identification of bis-1,3-phenyl guanylhydrazone <b>2a</b> as an effective new compound for the treatment of amyotrophic lateral sclerosis, in this work we analyze the possible binding sites of this molecule to the VPS35/VPS29 dimer of the retromer complex. This evidence concerns the gene VPS35 and amyotrophic lateral sclerosis.